Victoria Kaestner

Cancer Drugs Approved Based on Biomarkers and Not Tumor Type—FDA Approval of Pembrolizumab for Mismatch Repair-Deficient Solid Cancers

Vinay Prasad, Victoria Kaestner, Sham Mailankody · JAMA Oncology · 2017 · 144 citations

Medicine, Oncology, Surgery +7

Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational study

Jeffrey Wagner, John Marquart, Julia Ruby et al. · BMJ · 2018 · 41 citations · Full text

Medicine, Oncology, Pharmacology +8

Most medical practices are not parachutes: a citation analysis of practices felt by biomedical authors to be analogous to parachutes

Michael Hayes, Victoria Kaestner, Sham Mailankody et al. · CMAJ Open · 2018 · 33 citations · Full text

Public Health, Public Health Ethics, Bioethics +6

The relation between publication rate and financial conflict of interest among physician authors of high-impact oncology publications: an observational study

Victoria Kaestner, Jonathan Edmiston, Vinay Prasad · CMAJ Open · 2018 · 15 citations · Full text

Social Sciences, Economics, Oncology +14